Announcements
- OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease
- ADS Program collapse
- Change of Record Time and Last Day of Dealings
- Webull Corporate Communications Service Platform
- OKYO Pharma Now Participating on the Webull Corporate Communications Service Platform
- Change of Delisting Date to 22 May 2023
More ▼
Key statistics
On Friday, OKYO Pharma Ltd (OK11:STU) closed at 1.35, 69.81% above the 52 week low of 0.795 set on Jul 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.31 |
---|---|
High | 1.35 |
Low | 1.31 |
Bid | 1.33 |
Offer | 1.49 |
Previous close | 1.32 |
Average volume | 0.00 |
---|---|
Shares outstanding | 33.78m |
Free float | 25.28m |
P/E (TTM) | -- |
Market cap | 51.35m USD |
EPS (TTM) | -10.84 USD |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼